Abstract:Oxidative stress to RGC-5 cells in culture was delivered by exposure to a combination of glutamate (Glu) and buthionine-S,R-sulfoximine (BSO). The effect of the insult on cell survival was quantified by the resazurin-reduction and a dead/live assays. Moreover, breakdown of DNA, the localisation of phosphatidylserine and reactive radical species (ROS) and its quantification were determined. In addition, various proteins and mRNAs were studied using Western blot, real time PCR and immunocytochemistry. ACS14, its sulfurated moiety ACS1 and aspirin were tested for their ability to blunt the negative effects of Glu/BSO on RGC-5 cells. In addition assays were carried out to see whether any of these substances influenced glutathione (GSH). Glu/BSO dose-dependently kills RGC-5 cells by a mechanism that involves an elevation of ROS accompanied by a breakdown of DNA, expression of phosphatidylserine and the activation of p38 MAPK. The process is unaffected by the pan caspase inhibitor z-VAD-fmk, does not involve the activation of apoptosis inducing factor (AIF) but is sensitive to active necrostatin-1. In cell viability studies (resazurin-reduction assay), ACS1 and ACS14 equally counteracted the negative effects of 5 mM Glu/BSO to RGC-5 cells but aspirin was only effective with a milder oxidative stress (1 mM Glu/BSO). In all other assays ACS14 was very much more effective than aspirin at counteracting the influence of 5 mM Glu/BSO. Moreover, ACS14 and ACS1 directly stimulated GSH while aspirin was ineffective. In addition the neuroprotecive effect of ACS14 was specifically blunted by the non-specific potassium channel blocker glibenclamide. Also the up-regulation of Bcl-2, HO-1 and XIAP induced by 5 mM Glu/BSO were all attenuated to a greater extent by ACS14 (20 μM) than aspirin (20 μM). These data show that ACS14 is a very effective neuroprotectant when compared with aspirin. ACS14 maintains its aspirin characteristics and has the ability to release H 2S. The combined multiple actions of aspirin and H 2S in the form of ACS14 is worthy to consider for possible use in the treatment of glaucoma. © 2012 Elsevier Ltd. All rights reserved.

Effect Of A(2a) Receptor Antagonist (Sch 442416) On The Mrna Expression Of Glutamate Aspartate Transporter And Glutamine Synthetase In Rat Retinal Muller Cells Under Hypoxic Conditions In Vitro

A2AR Antagonists Upregulate Expression of GS and GLAST in Rat Hypoxia Model

Effect of SCH442416 on Glutamate Uptake in Retinal Müller Cells at Increased Hydrostatic Pressure.

The Effect of A 2A Receptor Antagonist (SCH 442416) on the Mrna Expression of Kir 2.1 and Kir 4.1 Channels in Rat Retinal Müller Cells under Hypoxic Conditions in Vitro.

Effect of Hypoxia on the Glutamate Transporter and Glutamine Synthetase in Mouse Retinal Müller Cells

Effect of Adenosine and Adenosine Receptor Antagonist on Müller Cell Potassium Channel in Rat Chronic Ocular Hypertension Models

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Effect of Adenosine and Adenosine Receptor Antagonists on Retinal Müller Cell Inwardly Rectifying Potassium Channels under Exogenous Glutamate Stimulation

[Study on Glutamate Substrate-Induced Regulation on Expression of Glutamate Transporter GLAST of Mouse Retinal Müller Cells].

[Effect of Glutamate on Vascular Endothelial Growth Factor Mrna and Protein Expressions in Hypoxic Rat Astrocytes in Vitro].

BDNF regulates GLAST and glutamine synthetase in mouse retinal Müller cells.

Inhibitory Effect of Synthetic Small Interfering Rnas on Glial Fibrillary Acidic Expression in Astrocytes

Altered expression of glutamate transporters under hypoxic conditions in vitro

Regulation of transforming growth factor alpha on glutamate transpoter of retinal M(u)ller cells in mice

Glutamate Enhances the Expression of Vascular Endothelial Growth Factor in Cultured SD Rat Astrocytes

Effect of the A2A Adenosine Receptor on the Expression of Vascular Endothelial Growth Factor under High Glucose Conditions in Human Retinal Pigment Epithelium Cells

Group I metabotropic glutamate receptor agonist DHPG modulates Kir4.1 protein and mRNA in cultured rat retinal Müller cells.

Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14)

Effect of high glucose on rat retinal Müller cells cultured in vitro

Erythropoietin Protects Müller Cells Through Maintaining Its Expression of Glutamate-Aspartate Transporter

Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid.